USPTO-FDA Listening Session — Voices From Patient And Patent Advocates - Patent
On January 19, 2023, the U.S. Patent and Trademark Office (USPTO) and Food and Drug Administration (FDA) held a "listening session" focusing on USPTO-FDA collaboration initiatives proposed...
Source: mondaq.com
